Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells

Norman Putzki,Manoj Baranwal,Barbara Tettenborn,Volker Limmroth,Ernst Kreuzfelder

Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells

2010

Norman Putzki
Manoj Baranwal
Barbara Tettenborn
Volker Limmroth
Ernst Kreuzfelder

Background: Natalizumab is a humanized monoclonal antibody directed against very late activation antigen 4 (VLA-4) and has a potent effect on disease activity in multiple sclerosis.

Keywords:

Lymphokine-activated killer cell
Natural killer cell
Natalizumab
Medicine
Immunology
Interleukin 21
Antigen
Virology
Natural killer T cell
ZAP70
B cell
Monoclonal antibody
Multiple sclerosis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations